4//SEC Filing
LAZARUS ROCHELLE B 4
Accession 0000899243-21-022672
CIK 0001821825other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 8:33 PM ET
Size
7.5 KB
Accession
0000899243-21-022672
Insider Transaction Report
Form 4
LAZARUS ROCHELLE B
Director
Transactions
- Award
Phantom Stock
2021-06-04$36.05/sh+8,772$316,231→ 8,772 total→ Common Stock (8,772 underlying)
Holdings
- 460
Common Stock
- 175(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Shares acquired in a pro rata distribution by Merck & Co., Inc. ("Merck") of shares of Organon & Co. ("Organon") in connection with the separation of Organon from Merck (the "Separation").
- [F2]1-for-1
- [F3]Consists of (i) a one-time grant of 5,549 phantom units awarded in connection with the Separation, which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases.
Documents
Issuer
Organon & Co.
CIK 0001821825
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001082206
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 8:33 PM ET
- Size
- 7.5 KB